Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
250 GBX | +4.17% | +61.29% | -18.03% |
05-03 | Kelso raises stake in NCC; Transense joins project | AN |
04-30 | Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.03% | 219M | |
+7.52% | 113B | |
+11.38% | 106B | |
+1.48% | 22.27B | |
-12.64% | 22.22B | |
-5.10% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- FARN Stock
- News Faron Pharmaceuticals Oy
- Transcript : Faron Pharmaceuticals Oy, 2023 Earnings Call, Mar 13, 2024